Why Clinical AI Performance Matters When Choosing Glass Health

If you are building a product that answers medical questions, reasons through cases, drafts clinical documentation, or supports triage, Glass Health is a strong choice. We give your team clinically evaluated, evidence-grounded reasoning with citations, backed by clinical benchmark performance and HIPAA-supported deployment, so you can ship features your users can check rather than simply trust.

You can explore the Glass Developer API to see what it supports, or start in Glass API settings when you are ready to build.

Clinical performance shapes the product you can build

Every clinical AI feature makes an implicit promise to its user. A question-answering feature promises that the answer reflects current evidence. A diagnostic support feature promises that the reasoning holds up against the details of the case. A documentation feature promises that nothing important was dropped or invented.

Whether you can keep those promises depends on the clinical performance of the system underneath. That is why clinical AI API benchmarks belong near the top of your evaluation, alongside price and ease of integration. A model that writes confident prose is not automatically a model that reasons well about a patient with three interacting conditions and a long medication list.

Performance also determines what your product is allowed to be. Weak clinical accuracy pushes a team toward narrow, heavily hedged features. Strong, evaluated performance lets a team design richer workflows, because the output is worth a clinician's attention and can be reviewed efficiently. Glass is built for the second path.

General fluency is a different thing from clinical judgment

General-purpose language models can be capable writers and broad generalists. Clinical products also need evidence of performance on medical work, including questions involving complex patient histories, interacting conditions and treatment decisions.

Clinical judgment involves different skills. It means weighing findings against each other, recognizing when a presentation is dangerous, knowing what the current guideline says rather than what an older textbook said, and being honest about uncertainty. A system can be highly fluent and still miss a red flag, overstate a drug interaction, or cite a recommendation that has since changed.

This is why evaluating a clinical system requires clinical tests. Glass approaches evaluation from that starting point. Glass is evaluated by clinicians and benchmarked on clinical use cases using a 900-question clinical accuracy benchmark suite that covers medical knowledge and reasoning, diagnostic reasoning, clinical note generation, and hallucination detection. Those four areas map directly onto the features product teams actually ship.

Within that clinical benchmark suite, Glass 5.5, the current recommended model for the Developer API, outperforms the leading frontier foundation models. That is a statement about our clinical suite specifically, and it is the kind of evidence you should expect from any vendor asking you to build clinical features on their platform.

Independent benchmark evidence

Internal evaluation is necessary, and independent evaluation adds a second perspective that buyers should value. The Medical AI Superintelligence Test (MAST), run by the ARISE AI Research Network, evaluates clinical AI systems on clinical reasoning, patient safety, and diagnostic case analysis. Its technical results list Glass 5.6 Max as follows.

These preview scores were checked on September 13, 2026 and can change. They apply to the evaluated Glass 5.6 Max system. The Developer API currently recommends Glass 5.5, so the figures should not be represented as measured performance of that API model.

What matters more than any single figure is what each category represents for your product. Clinical reasoning measures whether a system can work through a case the way a clinician would, connecting findings to plausible explanations and next steps. That is the foundation of any diagnostic support, case summary, or assessment-and-plan feature.

The safety category asks a different question: does the system avoid recommendations that could harm a patient? For a product owner, this is the category most closely tied to risk. A system that reasons well but occasionally suggests something dangerous creates review burden and liability that the reasoning score alone will not reveal.

CPC cases are classic diagnostic challenges, often complex presentations with a known final diagnosis. Performance here speaks to whether a system can synthesize a large amount of clinical detail into a correct conclusion, which is exactly what a differential diagnosis feature is asked to do.

MAST's own methodology notes that benchmark comparison helps distinguish clinical systems while performance in a specific product still needs assessment in its intended use. That is sound advice. Benchmarks should narrow your shortlist and set expectations; your own review of outputs in your workflow should confirm the fit.

Where clinical performance shows up in real product scenarios

Performance is abstract until you attach it to a feature. The following scenarios illustrate what a team can build on Glass and how clinical reasoning quality affects the result. They are possibilities for your roadmap, described in terms of what Glass contributes within your product.

Evidence-based clinical question answering

A team building a point-of-care reference tool, a pharmacist support application, or a clinician-facing assistant can use Glass to answer clinical questions grounded in current guidelines and literature. When a user asks about first-line therapy for a condition in a patient with reduced kidney function, Glass reads the question, searches current clinical guidelines and medical literature, and returns an answer grounded in that evidence.

Citations help a clinician examine the evidence behind an answer, an educator point learners toward supporting literature, and a clinical team review the content presented in its product. That makes the supporting evidence part of the user experience.

Performance matters here because currency and accuracy are the whole value of the feature. An answer built on an outdated recommendation is worse than no answer, because it looks authoritative. Glass's grounding in current evidence and its hallucination-detection evaluation are designed to address exactly this failure mode. The cited answer becomes a starting point for a decision, with the evidence visible and the clinician in control.

Differential diagnosis and treatment planning

A team building diagnostic support for emergency medicine, hospital medicine, or primary care can supply patient context from within its product and ask Glass to reason through the case. Glass approaches differential diagnosis the way a master clinician would, reasoning across the history, exam, lab values, imaging, medications, and any other patient context you provide.

For treatment planning, Glass generally produces an assessment and plan that includes an overall analysis of the patient, problem-based assessments for the major active issues, diagnostic next steps, and treatment or management next steps. A product can present that structure directly, letting a clinician accept, edit, or reject each element.

This is where clinical reasoning and diagnostic performance pay off most visibly. A differential that ranks the dangerous possibility appropriately and explains why is useful; one that lists common conditions without weighing the specific findings is noise. Glass is particularly strong at analyzing large amounts of unstructured patient data, which suits products that receive long histories or transferred records rather than tidy summaries. Because decisions here affect care, the output should be reviewed by a clinician, and Glass's structured, cited reasoning is designed to make that review efficient rather than burdensome. For a deeper look at building this kind of feature, see our guide to building clinical decision support with an API.

Clinical documentation and patient-facing materials

A team building an ambient scribe, an inpatient workflow tool, or a discharge platform can use Glass to draft many forms of clinical documentation, including H&Ps, HPIs, clinic notes, progress notes, discharge summaries, prior authorization letters, and handoff notes. The Scribing API transcribes clinical encounters from audio recordings and can generate structured notes such as SOAP notes, H&Ps, and visit summaries directly from the recording.

Glass also generates patient-facing documentation in plain language, including discharge instructions, care plan summaries, medication guides, condition education, and return precaution instructions. A discharge product can produce a clinician-facing summary and a patient-facing instruction sheet from the same encounter, each written for its audience.

Documentation quality matters because both omissions and invented details can make a draft less useful. Glass’s clinical benchmark suite includes note generation and hallucination detection. For buyers building documentation products, that makes the evaluation relevant to the work their users will review.

Evidence-based triage and intake

A team building a symptom checker, a nurse triage tool, a digital front door, or an escalation layer for a telehealth service can use Glass for evidence-based triage. Glass evaluates patient-reported symptoms, vital signs, and intake data against clinical criteria, identifies high-risk features, and returns structured triage output that can support intake systems, nurse triage tools, and escalation logic in patient-facing or provider-facing products.

Triage is a safety problem before it is a convenience problem. The cost of an overly cautious system is wasted visits; the cost of an under-cautious one is a missed emergency. This asymmetry makes the safety dimension of clinical performance the deciding factor for triage products. Glass's independent evaluation on First Do No Harm and its clinician-informed development speak directly to that concern.

Within your product, a structured triage result can route a patient to the right level of care, flag high-risk features for a nurse, or trigger a callback. The clinical team defines the escalation rules and reviews the pathways; Glass supplies the evidence-informed assessment that feeds them.

A clinical reasoning step inside a larger workflow

A team can build a clinical assistant within a broader healthcare product: a care coordination experience that prepares a case summary, an evidence assistant that answers a clinical question, or a tool that helps prepare documentation for review. Glass brings clinical reasoning to those experiences.

For an agent builder, clinical expertise is a meaningful part of the offering. Glass combines clinical reasoning, evidence grounding and citations, giving the team a clinical foundation for products that involve medical information. Our guide to clinical AI for agents explores more product possibilities.

What cited evidence lets your team ship

Citations are often treated as a nice-to-have. For clinical products they are closer to a design requirement. A cited answer gives a clinician a fast path to verification, which is what makes it acceptable to show AI output at the point of care at all. A cited answer also gives your product something to display, log, and audit.

A clinician considering an answer needs a way to examine its basis. Citations bring the supporting literature closer to the answer and help the user judge whether the information applies to the case. That is a concrete trust feature a team can offer in a Glass-powered product.

Citations are not a guarantee of correctness, and we do not promise that every sentence in every answer carries a perfect reference. What citations do is make errors findable and correct answers checkable. For a team that must explain its product to a clinical governance committee, that property is worth a great deal.

Purpose-built clinical capabilities versus assembling your own

A general model API is a legitimate way to build clinical features. The trade-off is where the clinical work happens. With a general model, your team takes on the job of grounding answers in current evidence, designing clinical output structures, evaluating clinical accuracy, testing for unsafe recommendations, and maintaining all of it as guidelines change.

Choosing Glass moves that work to a vendor whose entire product is clinical reasoning. Glass is developed with clinician evaluation, benchmarked on clinical tasks, and independently assessed on clinical reasoning and safety. Its capabilities span question answering, diagnosis, treatment planning, documentation, scribing, patient education, and triage, so one integration can support a broad product surface.

Breadth matters for a growing roadmap. A team might begin with clinical Q&A and later add documentation or patient education. Glass supports those related capabilities, offering room to expand with one clinical technology partner. Our overview of choosing a healthcare AI API discusses the broader buying decision.

Performance you can deploy in regulated settings

Glass is end-to-end HIPAA compliant, and organizations using the Glass Developer API in HIPAA-regulated workflows may obtain a Business Associate Agreement for API use through Glass API settings. Buyers can consider clinical performance and a defined path for regulated use together.

The BAA covers Glass API use; your finished product retains its own compliance responsibilities, and we recommend synthetic or de-identified patient data during development and evaluation. Both are ordinary expectations for any clinical software project. For teams that need more detail, our guide to a HIPAA-compliant AI API walks through the considerations.

Commercially, Glass Developer API access starts with a subscription minimum of $250 per month, with usage above that floor charged separately. That structure suits teams that want to build and evaluate before committing to a large contract, and it scales with the product as it grows.

How to judge any vendor's clinical evidence

You do not need a research background to evaluate vendor claims well. A handful of plain-language questions will separate substantive clinical evidence from marketing.

• Was the system evaluated on clinical tasks, or on general benchmarks? Ask for results that cover medical reasoning, diagnosis, documentation, and safety specifically.
• Were clinicians involved in evaluation? Clinician review catches errors that automated scoring misses, especially around safety and clinical relevance.
• Is there independent evidence in addition to the vendor's own? External evaluation such as MAST provides a second view, even if it measures a different version than the one you deploy.
• Does the system show its evidence? Citations tied to specific claims let your clinical team verify outputs rather than take them on faith.
• Does the vendor say which version was tested? Clear version labeling is a sign the vendor takes its own evidence seriously.
• Can you test it on your own cases before committing? Benchmarks set expectations; your workflow confirms fit.

We answer each of these questions directly: clinician evaluation, a clinical benchmark suite spanning the tasks that matter, independent MAST results, inline citations, explicit version labeling, and an entry price that supports evaluation before scale.

When Glass is the right choice

Choose Glass when the clinical quality of the output is central to your product's value. That includes clinician-facing assistants, diagnostic and planning support, scribing and documentation tools, patient education features, triage and intake flows, and agentic workflows that need a dependable clinical reasoning step.

Choose Glass when your users will want to verify answers, because citations and structured reasoning make verification fast. Choose Glass when you expect to deploy in HIPAA-regulated settings, because the BAA is available for API use from the start. And choose Glass when your roadmap is likely to expand across clinical use cases, because a single platform already covers the breadth you will need.

We do not claim that Glass is the best tool for every task a health technology company will ever build. It is built to be an excellent choice for the clinical reasoning at the heart of your product, evaluated in the ways that matter for patient care, and ready to deploy responsibly.

Frequently asked questions

Are clinical AI API benchmarks enough to choose a vendor?

They are the right starting point, not the finish line. Benchmarks such as Glass's clinical suite and independent MAST results tell you a system performs well on clinical reasoning, safety, and diagnosis. You should still review outputs on cases representative of your own workflow before launch, as MAST's methodology itself recommends.

Which Glass model do the MAST scores apply to?

The cited MAST scores apply to Glass 5.6 Max. The Developer API currently recommends Glass 5.5. Buyers should keep those offerings distinct and consult performance evidence for the model they intend to use.

Does every Glass answer include citations?

Glass supports clinical answers with citations that help users examine the supporting evidence. Citations aid review; they do not guarantee correctness or replace clinical judgment.

Why choose Glass rather than a general model API?

A general model can be made to perform clinical tasks, but your team then owns the evidence grounding, clinical output design, accuracy evaluation, and safety testing. Glass supplies those as part of a purpose-built clinical offering with clinician-informed development, clinical benchmarks, and independent evaluation.

Can we use Glass with protected health information?

Yes. Glass is end-to-end HIPAA compliant, and organizations using the Developer API in regulated workflows may obtain a BAA for API use through API settings. We recommend synthetic or de-identified data during development and evaluation, and your finished product carries its own compliance responsibilities.

Does Glass connect to our medical records system?

Glass processes the clinical context your product supplies. Your product decides what information to send and what to do with the response. Glass does not independently retrieve charts, place orders, or take clinical actions.

How do we get started?

Visit Glass API settings, accept the BAA if your workflow requires it, and create an API key. From there you can evaluate Glass on de-identified cases from your own domain, then build the features that fit your product.

Build on evaluated clinical performance

Clinical AI is judged by patients and clinicians on whether it is right, safe, and checkable. Glass is developed and evaluated with those standards in mind, and it offers the breadth to support a product that grows.

Explore the Glass Developer API or get started in Glass API settings. The API documentation is available when your team is ready to build.